Product Information
TEMOZOLOMIDE 250 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $20.5332 per EA under NDC 31722041631. Its NADAC has been published 49 times since Jul 23, 2025.
Strength
250 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722041631
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
10/22/2025
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210030On Market Since
8/23/2024
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 250 MG CAPSULE has been published 49 times since Jul 23, 2025, and over the history we have for it it has declined 11.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.5332 per EA |
|---|---|
| All-time high | $23.2652 (Aug 13, 2025) |
| All-time low | $20.5332 (Oct 22, 2025) |
| 52-week high | $23.2652 |
| 52-week low | $20.5332 |
| Median price | $20.5332 |
| Average price | $21.0071 |
| Largest weekly change | -6.2% (Oct 22, 2025) |
| Weeks tracked | 49 |
| Tracking since | Jul 23, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the TEMOZOLOMIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 250 MG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $20.5332 per EA (NDC 31722041631), effective Jun 24, 2026.
How has the price of TEMOZOLOMIDE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 250 MG CAPSULE has declined 11.7%. It has been tracked across 49 weekly CMS publications since Jul 23, 2025.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 250 MG CAPSULE?
Since Jul 23, 2025, the NADAC for TEMOZOLOMIDE 250 MG CAPSULE has ranged from a low of $20.5332 (Oct 22, 2025) to a high of $23.2652 (Aug 13, 2025), with a median of $20.5332 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 250 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TEMOZOLOMIDE 250 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures TEMOZOLOMIDE 250 MG CAPSULE?
TEMOZOLOMIDE 250 MG CAPSULE (NDC 31722041631) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification